Oral and upper gastrointestinal Crohn's disease

E-ISSN： 1440-1746|33|2|355-364

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.33, Iss.2, 2018-02, pp. : 355-364

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of oral tobacco use and smoking on outcomes of Crohn's disease in India

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 1, 2018-01 ,pp. : 134-140

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 269-2813, Iss. 10, 2015-11 ,pp. : 1170-1181

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 10, 2015-11 ,pp. : 1170-1181

John Wiley & Sons Inc

Access to resources Recommend Favorite

Disorders of the upper gastrointestinal tract

Reviews in Clinical Gerontology, Vol. 5, Iss. 4, 1995-11 ,pp. : 399-412

Cambridge University Press

Access to resources Recommend Favorite

Disorders of the upper gastrointestinal tract

Reviews in Clinical Gerontology, Vol. 1, Iss. 1, 1991-02 ,pp. : 29-42

Cambridge University Press

Access to resources Recommend Favorite